ARYA Sciences Acquisition... (ARYD)
NASDAQ: ARYD
· Real-Time Price · USD
6.64
-2.46 (-27.03%)
At close: Jul 31, 2024, 10:00 PM
ARYA Sciences Acquisition Corp IV Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -612K | -2.75M | -960K | -78.85K | -969K | -271K | -180K | -305K | -253K | -1.12M | -5.11M | -167K | -226K |
Interest Income | 511.75K | 525.13K | 504.6K | 460.36K | 1.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -246K | -2.22M | -455K | 381.51K | 160.25K | -1.71M | 3.18M | -196K | -211K | -1.1M | -5.09M | -162K | -210K |
Net Income | -246K | -2.22M | -455K | 381.51K | 160.25K | -3.14M | 3.18M | -196K | -211K | -1.1M | -5.09M | -162K | -210K |
Selling & General & Admin | 611.74K | 2.75M | 959.67K | 78.85K | 968.6K | 271.14K | 180.41K | 304.81K | 252.72K | 1.12M | 5.11M | 166.91K | 225.58K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 611.74K | 2.75M | 959.67K | 78.85K | 968.6K | 271.14K | 180.41K | 304.81K | 252.72K | 1.12M | 5.11M | 166.91K | 225.58K |
Interest Expense | n/a | 1.13M | n/a | n/a | n/a | 1.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 611.74K | 2.75M | 959.67K | 78.85K | 968.6K | 271.14K | 180.41K | 304.81K | 252.72K | 1.12M | 5.11M | 166.91K | 225.58K |
Income Tax Expense | n/a | -2.75K | -959 | -78.85 | -1.13M | 1.44M | -3.36M | -109K | -41.54K | n/a | -12.52K | n/a | n/a |
Shares Outstanding (Basic) | 7.78M | 7.93M | 7.43M | 7.43M | 15.06M | 19.19M | 19.19M | 15.45M | 19.19M | 19.19M | 19.19M | 19.19M | 19.19M |
Shares Outstanding (Diluted) | 7.78M | 7.93M | 7.43M | 7.43M | 15.06M | 19.19M | 19.19M | 15.45M | 19.19M | 19.19M | 19.19M | 19.19M | 19.19M |
EPS (Basic) | -0.03 | -0.28 | -0.06 | 0.05 | 0.09 | -0.16 | 0.34 | -0.00 | -0.01 | -0.06 | -0.27 | -0.01 | -0.01 |
EPS (Diluted) | -0.03 | -0.28 | -0.06 | 0.05 | 0.09 | -0.16 | 0.34 | -0.00 | -0.01 | -0.05 | -0.27 | -0.01 | -0.01 |
EBITDA | -612K | 37.67K | -960K | -78.85K | -969K | -271K | -180K | 108.81K | 41.54K | 20K | 12.52K | -171K | 15.33K |
EBIT | n/a | -1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.11M | n/a | n/a |
Depreciation & Amortization | 611.74K | 1.13M | 959.67K | 78.85K | 968.6K | 271.14K | 180.41K | 304.81K | 252.72K | 32.33K | 5.11M | 166.91K | n/a |